In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...
The brokerage highlighted that there are several growth opportunities for the company going ahead including the growing CS ...
Executives from Impact Analytics and Carters Inc. discuss demographic shifts, changing compositions, weight loss drugs and ...
Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy ...
If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE: LLY) is having a bit of an off quarter.
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
23h
Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback